BF
| |
Biotechnology Fund | RYOIXMutual Fund | |
| RYDEX SERIES FUNDS | |
| Last update 2026-06-02 | 72 Stocks (7 new) |
| Value $133.00 Mil | Turnover 25 % |
Biotechnology Fund Top Holdings of 2026-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV | AbbVie Inc | 45,923 | 9,987.8 | +27.91% | 7.500 | +1.64% | 0.000 | +18.92% | +10.76% | 439,931.4 | Drug Manufacturers | |
AMGN | Amgen Inc | 20,093 | 7,069.7 | +21.66% | 5.310 | +0.95% | 0.000 | +2.86% | +11.75% | 194,581.0 | Drug Manufacturers | |
GILD | Gilead Sciences Inc | 48,042 | 6,695.6 | +20.58% | 5.020 | +0.86% | 0.000 | -6.66% | +4.68% | 157,592.5 | Drug Manufacturers | |
VRTX | Vertex Pharmaceuticals Inc | 12,119 | 5,411.6 | +14.34% | 4.060 | +0.51% | 0.000 | +10.14% | +10.23% | 126,838.6 | Biotechnology | |
REGN | Regeneron Pharmaceuticals Inc | 6,224 | 4,808.9 | +20.81% | 3.610 | +0.62% | 0.010 | -15.75% | -17.30% | 66,742.6 | Biotechnology | |
ALNY | Alnylam Pharmaceuticals Inc | 10,632 | 3,517.8 | +33.79% | 2.640 | +0.67% | 0.010 | -9.10% | -24.98% | 39,827.5 | Biotechnology | |
INSM | Insmed Inc | 20,277 | 3,315.7 | +39.56% | 2.490 | +0.71% | 0.010 | -26.86% | -37.97% | 23,399.9 | Biotechnology | |
ONC | BeOne Medicines Ltd | 10,395 | 3,087.0 | +40.87% | 2.320 | +0.67% | 0.010 | +1.49% | -7.48% | 31,026.7 | Biotechnology | |
NTRA | Natera Inc | 14,145 | 2,828.9 | +31.15% | 2.120 | +0.50% | 0.010 | +36.15% | +16.57% | 38,245.7 | Medical Diagnostics & Research | |
UTHR | United Therapeutics Corp | 4,711 | 2,793.5 | +13.87% | 2.100 | +0.26% | 0.010 | +3.07% | +12.65% | 23,297.7 | Drug Manufacturers |
Biotechnology Fund's Historical Top Holdings Breakdowns
Biotechnology Fund's Top Stock Picks
View Full List
| Ticker |
|---|
SVIV |
| EXAS Unlock Delisted |
ABBV |
AZN |
| RNAM Unlock Delisted |
| CDTX Unlock Delisted |
COGT |
AMGN |
GILD |
APGE |
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
SVIV | Spring Valley Acquisition Corp IV | 2026-03-31 | Sold Out Sold Out | -2.25% | 9.87 ($9.89) 10.02 | $10.18 | 2.93% | Sold Out | 0 | -26,373 | |
| EXAS Unlock Delisted | Exact Sciences Corp | 2026-03-31 | Sold Out Sold Out | -1.79% | 101.61 ($102.96) 104.91 | $104.91 | 1.89% | Sold Out | 0 | -18,983 | |
ABBV | AbbVie Inc | 2026-03-31 | Add Add | +1.64% | 204.93 ($221.82) 236.19 | $248.68 | 12.11% | Add 27.91% | 45,923 | 10,020 | |
AZN | AstraZeneca PLC | 2026-03-31 | New Buy New Buy | +1.62% | 175 ($192.35) 209.48 | $188.86 | -1.81% | New holding | 10,974 | 10,974 | |
| RNAM Unlock Delisted | Avidity Biosciences Inc | 2026-03-31 | Sold Out Sold Out | -1.33% | 70.63 ($71.2) 71.47 | $71.34 | 0.20% | Sold Out | 0 | -19,911 | |
| CDTX Unlock Delisted | Cidara Therapeutics Inc | 2026-03-31 | Sold Out Sold Out | -1.02% | 221.03 ($221.3) 221.38 | $221.38 | 0.04% | Sold Out | 0 | -4,967 | |
COGT | Cogent Biosciences Inc | 2026-03-31 | New Buy New Buy | +1.00% | 33.38 ($36.93) 39.97 | $37.50 | 1.54% | New holding | 34,752 | 34,752 | |
AMGN | Amgen Inc | 2026-03-31 | Add Add | +0.95% | 320.72 ($356.5) 388.16 | $359.90 | 0.95% | Add 21.66% | 20,093 | 3,577 | |
GILD | Gilead Sciences Inc | 2026-03-31 | Add Add | +0.86% | 118.3 ($140.04) 155.8 | $127.14 | -9.21% | Add 20.58% | 48,042 | 8,198 | |
APGE | Apogee Therapeutics Inc | 2026-03-31 | New Buy New Buy | +0.76% | 62.13 ($72.62) 84.17 | $132.66 | 82.68% | New holding | 12,066 | 12,066 |
Biotechnology Fund Total Holding History ($B)
Biotechnology Fund's Asset Allocation
Biotechnology Fund Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
Biotechnology Fund's Hypothetical Growth since 2026-03-31
Biotechnology Fund's Yearly Returns
This information is only displayed for Gurus who publicly disclose audited performance records; most hedge funds and private investment firms do not publish such data or only provide limited historical performance information.
| Year | Portfolio % | % | Excess Gain % |
|---|
Biotechnology Fund's Holdings Heat Map
Size field:
Biotechnology Fund's Holdings Bubble Chart
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers